Litigation

Recent Posts

3rd Levaquin MDL Bellwether Trial Ends With 3rd Verdict For Johnson & Johnson
Posted on 27 Jan 2012 by Tom Moylan

MINNEAPOLIS - (Mealey's) The third Levaquin multidistrict litigation tendon rupture trial ended Jan. 26 with a defense verdict, defendant Johnson & Johnson's third compared to one plaintiff victory ( Clifford Straka v. Johnson & Johnson... Read More

Tags: Minnesota Senior Citizen and Disabled Person's Consumer Fraud and Deceptive Trade Practices Act , drugs , Clifford Straka , Minnesota Consumer Fraud Act , Johnson , Levaquin , tendon rupture , Litigation , multidistrict litigation , Clifford Straka v. Johnson &amp , verdict , Janssen Pharmaceuticals , Johnson &amp

Arkansas High Court Reverses $1.2B Risperdal Verdict For State Law Violations
Posted on 21 Mar 2014 by Tom Moylan

LITTLE ROCK, Ark. — (Mealey’s) In a 4-3 decision, the Arkansas Supreme Court on March 20 reversed a $1.2 billion verdict against Janssen Pharmaceuticals for violating state law in its marketing of the antipsychotic drug Risperdal ( Ortho-McNeil... Read More

Tags: drugs , Risperdal , product liability , Litigation , et al. v. State of Arkansas , Inc. , Ortho-McNeil-Janssen Pharmaceuticals , Arkansas , verdict , torts , Janssen Pharmaceuticals , antipsychotic drug , Arkansas Supreme Court

N.J. Risperdal Jury Finds Diabetes Warning Lacking, But Drug Didn't Cause Disease
Posted on 17 Feb 2012 by Tom Moylan

NEW BRUNSWICK, N.J. - (Mealey's) A Risperdal personal injury trial ended Feb. 16 in a defense verdict for Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. after a New Jersey state court jury found that Janssen failed to warn about the... Read More

Tags: Gary D. Skala , drugs , Risperdal , et al. , Johnson , personal injury , AstraZeneca , New Jersey , Gary D. Skala v. Johnson &amp , Litigation , amp , mass tort , Eli Lilly and Co. , Zyprexa , verdict , diabetes , Seroquel , Janssen Pharmaceuticals , Johnson &amp , antipsychotic drug

Pennsylvania State Court Jury Awards $2.5 Million In Risperdal Gynecomastia Trial
Posted on 24 Feb 2015 by Tom Moylan

PHILADELPHIA — (Mealey’s) A Pennsylvania state court jury on Feb. 24 awarded $2.5 million to the family of a man who claimed that the atypical antipsychotic drug Risperdal caused gynecomastia, or enlarged male breasts ( P.P., et al. v. Ortho... Read More

Tags: drugs , punitive damages , gynecomastia , Risperdal , atypical antipsychotic drug , Austin Pledger , Benita Pledger , et al. v. Ortho-McNeil-Janssen Pharmaceuticals , product liability , P.P. , Pennsylvania , Litigation , Inc. , Ortho-McNeil-Janssen Pharmaceuticals , enlarged male breasts , verdict , torts , Johnson & Johnson , Janssen Pharmaceuticals

Janssen Settles Some Pa. Topamax Birth Defect Cases, Will Appeal $3M Verdict
Posted on 11 Mar 2014 by Tom Moylan

PHILADELPHIA — (Mealey’s) Topamax manufacturer Janssen Pharmaceuticals on March 10 said it will appeal a $3 million March 7 birth defect verdict in the Philadelphia County Common Pleas Court even though it reached an agreement to resolve a... Read More

Tags: drugs , birth defect , Pennsylvania , Topamax , Litigation , Payton Anderson v. Janssen Pharmaceuticals , Settlement , verdict , torts , Janssen Pharmaceuticals